Skip to main content
logo
Honz Pharmaceutical Co., Ltd. (SHE:300086)
China flag China · Delayed Price · Currency is CNY
7.40
+0.18 (2.49%)
Apr 30, 2026, 3:04 PM CST

Honz Pharmaceutical Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Market Capitalization
3,3685,4752,2302,6422,7993,906
Market Cap Growth
44.53%145.51%-15.57%-5.63%-28.34%54.45%
Enterprise Value
3,7765,9672,6763,0333,1964,251
Last Close Price
7.4012.034.905.876.228.68
PE Ratio
---229.10-355.50
Forward PE
-36.3236.3236.3236.3236.32
PS Ratio
7.2311.754.723.575.224.67
PB Ratio
3.665.941.911.922.072.51
P/TBV Ratio
4.076.622.262.272.483.05
P/FCF Ratio
115.65188.01----
P/OCF Ratio
27.7845.1631.2137.3795.45344.77
EV/Sales Ratio
8.1012.805.664.105.975.08
EV/EBITDA Ratio
---22.93-126.48
EV/EBIT Ratio
---55.30--
EV/FCF Ratio
129.68204.91----
Debt / Equity Ratio
0.490.490.440.360.430.38
Debt / EBITDA Ratio
---3.79-15.09
Debt / FCF Ratio
15.3415.34----
Net Debt / Equity Ratio
0.420.420.340.260.230.22
Net Debt / EBITDA Ratio
-4.15-4.15-4.222.70-3.259.93
Net Debt / FCF Ratio
13.2913.29-18.87-5.33-10.58-1.60
Asset Turnover
0.250.250.230.330.230.33
Inventory Turnover
1.231.231.061.471.462.05
Quick Ratio
0.200.200.420.850.790.99
Current Ratio
0.520.520.891.601.331.49
Return on Equity (ROE)
-22.43%-22.43%-17.65%0.38%-13.61%0.67%
Return on Assets (ROA)
-5.31%-5.31%-4.73%1.54%-3.86%-0.13%
Return on Invested Capital (ROIC)
-11.23%-11.15%-9.51%0.71%-8.25%-0.14%
Return on Capital Employed (ROCE)
-13.30%-13.30%-10.60%3.10%-8.20%-0.30%
Earnings Yield
-6.83%-4.20%-9.70%0.44%-6.70%0.28%
FCF Yield
0.86%0.53%-0.94%-2.53%-1.06%-5.34%
Payout Ratio
---211.14%-370.22%
Buyback Yield / Dilution
-0.84%0.29%-1.34%-0.10%0.08%-0.29%
Total Shareholder Return
-0.84%0.29%-1.34%-0.10%0.08%-0.29%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.